Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use
- PMID: 22465385
- DOI: 10.1016/j.intimp.2012.03.009
Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use
Abstract
In this study, we examined the effects of cryoprotectant, freezing and thawing, and adenovirus (Adv) transduction on the viability, transgene expression, phenotype, and function of human dendritic cells (DCs). DCs were differentiated from cultured peripheral blood (PB) monocytes following Elutra isolation using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) for 6 days and then transduced using an Adv vector with an IL-12 transgene. Fresh, cryopreserved, and thawed transduced immature DCs were examined for their: 1) cellular concentration and viability; 2) antigenicity using an allogeneic mixed lymphocyte reaction (MLR); 3) phenotype (HLA-DR and CD11c) and activation (CD83); and 4) transgene expression based on IL-12 secretion. Stability studies revealed that transduced DCs could be held in cryoprotectant for as long as 75 min at 2-8°C prior to freezing with little effect on their viability and cellularity. Further, cryopreservation, storage, and thawing reduced the viability of the transduced DCs by an average of 7.7%; and had no significant impact on DC phenotype and activation. In summary, cryopreservation, storage, and thawing had no significant effect on DC viability, function, and transgene expression by Adv-transduced DCs.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.Int Immunopharmacol. 2008 Dec 20;8(13-14):1728-36. doi: 10.1016/j.intimp.2008.08.010. Epub 2008 Sep 13. Int Immunopharmacol. 2008. PMID: 18793758
-
Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.Shock. 2005 Jun;23(6):507-15. Shock. 2005. PMID: 15897802
-
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.Int J Oncol. 2006 Apr;28(4):947-53. Int J Oncol. 2006. PMID: 16525645
-
IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset.J Cell Sci. 2004 Jul 15;117(Pt 16):3435-45. doi: 10.1242/jcs.01162. Epub 2004 Jun 22. J Cell Sci. 2004. PMID: 15213252
-
Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.Cryobiology. 1998 Dec;37(4):362-71. doi: 10.1006/cryo.1998.2136. Cryobiology. 1998. PMID: 9917353
Cited by
-
Cryopreservation of Human Adipose-Derived Stem Cells for Use in Ex Vivo Regional Gene Therapy for Bone Repair.Hum Gene Ther Methods. 2018 Dec;29(6):269-277. doi: 10.1089/hgtb.2018.191. Epub 2018 Oct 25. Hum Gene Ther Methods. 2018. PMID: 30280937 Free PMC article.
-
Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies.J Transl Med. 2014 Sep 17;12:241. doi: 10.1186/s12967-014-0241-y. J Transl Med. 2014. PMID: 25223845 Free PMC article.
-
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.J Immunol Res. 2016;2016:5392623. doi: 10.1155/2016/5392623. Epub 2016 Sep 14. J Immunol Res. 2016. PMID: 27703987 Free PMC article.
-
Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.Cancer Gene Ther. 2014 Aug;21(8):317-32. doi: 10.1038/cgt.2014.32. Epub 2014 Jun 27. Cancer Gene Ther. 2014. PMID: 24971583
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials